
Lupin Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundationto Expand Access to Medication for COPD Patients.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundationto Expand Access to Medication for COPD Patients.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin